Ozempic may be reshaping the brain, scientists say - Ground News
A new NIH-funded study suggests that GLP-1 weight-loss drugs like Ozempic may influence brain reward circuits, specifically reducing dopamine signaling associated with pleasure-driven eating. Researchers are now investigating whether these medications could be repurposed to treat addiction and other behavioral disorders.
Why it matters
Understanding the neurological impact of popular weight-loss drugs is critical as their usage grows, potentially opening new avenues for treating substance abuse.
Ozempic may be reshaping the brain, scientists say
The article summarizes scientific findings from a peer-reviewed study without sensationalism.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in